Published in BMJ on November 21, 1998
Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ (1998) 10.71
Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med (2014) 4.14
Mortality registration and surveillance in China: History, current situation and challenges. Popul Health Metr (2005) 3.31
Avoidable global cancer deaths and total deaths from smoking. Nat Rev Cancer (2009) 3.14
Recent trends in physician diagnosed COPD in women and men in the UK. Thorax (2000) 3.02
China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol (2011) 2.82
Mortality and smoking in Hong Kong: case-control study of all adult deaths in 1998. BMJ (2001) 2.42
Smoking cessation in China: findings from the 1996 national prevalence survey. Tob Control (2001) 2.10
Economic burden of smoking in China, 2000. Tob Control (2006) 2.08
Cigarette smoking and exposure to environmental tobacco smoke in China: the international collaborative study of cardiovascular disease in Asia. Am J Public Health (2004) 2.02
Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies. Lancet (2015) 1.83
Smoking-related deaths averted due to three years of policy progress. Bull World Health Organ (2013) 1.68
Smoking among Chinese Americans: behavior, knowledge, and beliefs. Am J Public Health (2002) 1.68
Economic costs attributable to smoking in China: update and an 8-year comparison, 2000-2008. Tob Control (2011) 1.51
Trends in smoking and quitting in China from 1993 to 2003: National Health Service Survey data. Bull World Health Organ (2010) 1.34
Evaluation of the quality of cause of death statistics in rural China using verbal autopsies. J Epidemiol Community Health (2007) 1.31
Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51 804 patients. Br J Gen Pract (2010) 1.24
Counting the dead in China. Measuring tobacco's impact in the developing world. BMJ (1998) 1.14
Smoking patterns and sociodemographic factors associated with tobacco use among Chinese rural male residents: a descriptive analysis. BMC Public Health (2008) 1.07
Emerging tobacco-related cancer risks in China: A nationwide, prospective study of 0.5 million adults. Cancer (2015) 1.07
Smoking, quitting and mortality in an elderly cohort of 56,000 Hong Kong Chinese. Tob Control (2007) 1.06
The potential effects of tobacco control in China: projections from the China SimSmoke simulation model. BMJ (2014) 1.05
Employment and social "determinants" of smoking in urbanizing China: a representative survey. Nicotine Tob Res (2009) 1.00
The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics. J Thorac Oncol (2016) 0.99
Smoking, barriers to quitting, and smoking-related knowledge, attitudes, and patient practices among male physicians in China. Prev Chronic Dis (2008) 0.98
Prevalence and correlates of tobacco use among a sample of MSM in Shanghai, China. Nicotine Tob Res (2010) 0.96
Exhaled carbon monoxide and its associations with smoking, indoor household air pollution and chronic respiratory diseases among 512,000 Chinese adults. Int J Epidemiol (2013) 0.95
All-cause mortality and risk factors in a cohort of retired military male veterans, Xi'an, China: an 18-year follow up study. BMC Public Health (2007) 0.95
Associations of CYP2A6 genotype with smoking behaviors in southern China. Addiction (2011) 0.93
Methodologies used to estimate tobacco-attributable mortality: a review. BMC Public Health (2008) 0.92
The epidemiological profile of alcohol and other drug use in metropolitan China. Int J Public Health (2010) 0.88
Smoking and mortality in 81,344 drivers in Guangzhou, China. Occup Environ Med (2002) 0.88
Secondhand smoke exposure, indoor smoking bans and smoking-related knowledge in China. Int J Environ Res Public Health (2014) 0.86
Assessment of tobacco control advocacy behavioural capacity among students at schools of public health in China. Tob Control (2010) 0.86
Effectiveness of tobacco control among Chinese Americans: a comparative analysis of policy approaches versus community-based programs. Prev Med (2008) 0.85
The Harbin Cohort Study on Diet, Nutrition and Chronic Non-communicable Diseases: study design and baseline characteristics. PLoS One (2015) 0.82
COPD and its association with smoking in the Mainland China: a cross-sectional analysis of 0.5 million men and women from ten diverse areas. Int J Chron Obstruct Pulmon Dis (2015) 0.80
Smoke-free or not: a pilot evaluation in selected Beijing Hospitals. BMC Public Health (2013) 0.78
Special communication: China's first historic efforts to develop a tobacco control advocacy workforce via schools of public health. Tob Control (2009) 0.78
Population attributable risks of cigarette smoking for deaths of all causes, all cancers and other chronic diseases among adults aged 40-74 years in urban Shanghai, China. Chin J Cancer Res (2015) 0.77
Emerging tobacco hazards in China. Is assumption of no association between smoking and other causes of death valid? BMJ (1999) 0.77
Interrelations among smoking habits, casual blood pressure and intraocular pressure in middle and old-aged Japanese residents. Environ Health Prev Med (2002) 0.77
Mortality attributable to tobacco: review of different methods. Arch Public Health (2014) 0.77
China suboptimal health cohort study: rationale, design and baseline characteristics. J Transl Med (2016) 0.76
Association of green tea consumption with mortality from all-cause, cardiovascular disease and cancer in a Chinese cohort of 165,000 adult men. Eur J Epidemiol (2016) 0.76
Emerging tobacco hazards in China. Double standards apply with importation of tobacco into developing countries. BMJ (1999) 0.75
Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ (1994) 23.80
Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ (1998) 10.71
Smoking and death: the past 40 years and the next 40. BMJ (1994) 5.69
Early health effects of the emerging tobacco epidemic in China. A 16-year prospective study. JAMA (1997) 4.09
Tobacco-related deaths in China. Lancet (1987) 1.93
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41
Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J (1976) 28.28
The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst (1981) 25.60
Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet (1992) 25.28
Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet (1990) 25.12
Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet (1990) 24.72
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 24.57
Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ (1994) 23.80
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55
Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis (1985) 19.03
Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics (1973) 18.14
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet (2010) 18.09
A long-term follow-up study of women using different methods of contraception--an interim report. J Biosoc Sci (1976) 13.09
The natural history of chronic airflow obstruction. Br Med J (1977) 13.04
Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet (2004) 12.59
Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ (1998) 10.71
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet (2011) 10.62
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J (1985) 9.28
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med (1996) 8.57
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet (2008) 8.53
Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med (1997) 8.25
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet (2011) 8.24
Mortality from smoking worldwide. Br Med Bull (1996) 7.87
Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health (1978) 7.80
Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA (1998) 7.67
Why do we need some large, simple randomized trials? Stat Med (1985) 7.67
Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet (2015) 7.29
UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet (2000) 7.19
Chronic infections and coronary heart disease: is there a link? Lancet (1997) 7.18
Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. BMJ (1994) 6.74
Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet (2008) 6.67
Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol (1999) 6.42
Trials: the next 50 years. Large scale randomised evidence of moderate benefits. BMJ (1998) 6.13
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet (2005) 5.86
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med (1988) 5.81
Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet (2005) 5.50
Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ (1991) 5.45
Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J (1980) 5.21
Receptor mobility and receptor-cytoplasmic interactions in lymphocytes. Proc Natl Acad Sci U S A (1973) 5.13
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial. Lancet (2011) 5.08
The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis (1983) 4.90
Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst (2004) 4.83
Concanavalin A derivatives with altered biological activities. Proc Natl Acad Sci U S A (1973) 4.75
Mortality among doctors in different occupations. Br Med J (1977) 4.60
Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol (1994) 4.50
Sudden fall in breast cancer death rates in England and Wales. Lancet (1995) 4.50
Can dietary beta-carotene materially reduce human cancer rates? Nature (1981) 4.43
Lung cancer and indoor air pollution in Xuan Wei, China. Science (1987) 4.36
Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet (2008) 4.35
Tobacco--the growing epidemic. Nat Med (1999) 4.31
Early health effects of the emerging tobacco epidemic in China. A 16-year prospective study. JAMA (1997) 4.09
Evolution of digital organisms at high mutation rates leads to survival of the flattest. Nature (2001) 3.92
Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res (1976) 3.58
Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ (1997) 3.51
Carbon monoxide in breath in relation to smoking and carboxyhaemoglobin levels. Thorax (1981) 3.49
Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science (1995) 3.40
Why do we need systematic overviews of randomized trials? Stat Med (1987) 3.33
Hazard rate estimation under random censoring with varying kernels and bandwidths. Biometrics (1994) 3.12
How often does surgery for peptic ulceration eradicate Helicobacter pylori? Systematic review of 36 studies. BMJ (1998) 3.10
The covalent and three-dimensional structure of concanavalin A. Proc Natl Acad Sci U S A (1972) 3.09
Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation (2000) 3.05
Postcodes as useful markers of social class: population based study in 26 000 British households. BMJ (1999) 3.01
Hemichorea-hemiballism: an explanation for MR signal changes. AJNR Am J Neuroradiol (1998) 2.97
Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res (1971) 2.95
Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes (1992) 2.92
A carcinogenic potency database of the standardized results of animal bioassays. Environ Health Perspect (1984) 2.92
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet (2008) 2.91
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr (2010) 2.91
Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials. BMJ (1996) 2.90
Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer (2005) 2.88
Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet (1988) 2.84
Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother (1997) 2.84
Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ (1991) 2.81
Weibull distributions for continuous-carcinogenesis experiments. Biometrics (1973) 2.80
Urinary cotinine as marker of breathing other people's tobacco smoke. Lancet (1984) 2.74
Cancer and ageing in mice and men. Br J Cancer (1975) 2.74
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet (2015) 2.70
Unusual fragments in the subunit structure of concanavalin A. Proc Natl Acad Sci U S A (1971) 2.62
Low serum-vitamin-A and subsequent risk of cancer. Preliminary results of a prospective study. Lancet (1980) 2.60
Outcome of pregnancy in women using an intrauterine device. Lancet (1974) 2.58
The complete amino acid sequence of beta 2-microglobulin. Biochemistry (1973) 2.55
Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc Natl Acad Sci U S A (1997) 2.50